Health and Fitness Health and Fitness
Mon, October 18, 2010
[ Mon, Oct 18th 2010 ] - Market Wire
Somaxon Pharmaceuticals Announces Paragraph IV ANDA Filing for Silenor
[ Mon, Oct 18th 2010 ] - Market Wire
Synta Pharmaceuticals to Present at the Newsmakers in Biotechnology Conference
[ Mon, Oct 18th 2010 ] - Market Wire
Apricus Bio Announces First Patent Grant for Femprox® In Japan
[ Mon, Oct 18th 2010 ] - Market Wire
Bronstein, Gewirtz & Grossman, LLC Investigating .. s Law Violations at Gentiva Health Services, Inc.
[ Mon, Oct 18th 2010 ] - Market Wire
LifePoint Hospitals to Broadcast Its Third Quarter 2010 Conference Call Live on the Internet
[ Mon, Oct 18th 2010 ] - Market Wire
The Briscoe Law Firm Investigates AGA Medical Hol .. , Inc. Concerning the Buy-Out by St. Jude Medical
[ Mon, Oct 18th 2010 ] - Market Wire
American CareSource Holdings Adds Insurance Management Administrators Client Portfolio
[ Mon, Oct 18th 2010 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation Rela .. Acquisition of AGA Medical Holdings, Inc. - AGAM
[ Mon, Oct 18th 2010 ] - Market Wire
Kendall Law Group Investigates AGA Medical Holdings, Inc. Acquisition for Shareholders
[ Mon, Oct 18th 2010 ] - Market Wire
U.S. Food and Drug Administration Approves BARACL .. nt for Chronic Hepatitis B Patients with Evidence
[ Mon, Oct 18th 2010 ] - Market Wire
Teva Announces Launch of Generic Prevacid® SoluTab in the United States
[ Mon, Oct 18th 2010 ] - Market Wire
Tenet Hospitals Awarded 205 CIGNA HealthCare Quality Designations
[ Mon, Oct 18th 2010 ] - Market Wire
Zynex Increases Board of Directors
[ Mon, Oct 18th 2010 ] - Market Wire
Thermo Fisher Scientific Forms Scientific Advisory Board
[ Mon, Oct 18th 2010 ] - Market Wire
XIFAXAN 550 mg (Rifaximin) Demonstrates Acute and .. stipation Irritable Bowel Syndrome Symptoms: Data
[ Mon, Oct 18th 2010 ] - Market Wire
Mergenet Medical Launches Trach-Assist® First Airway Secretion Management System of Its Kind
[ Mon, Oct 18th 2010 ] - Market Wire
Micromet to Present at the 2010 Newsmakers in the Biotechnology Industry Conference
[ Mon, Oct 18th 2010 ] - Market Wire
BioScrip, Inc. to Host 2010 Third Quarter Earnings Call
[ Mon, Oct 18th 2010 ] - Market Wire
Gegevens ter verdere ondersteuning van onderzoek .. en gepresenteeerd op het 26ste congress van het E
[ Mon, Oct 18th 2010 ] - Market Wire
GenMark Diagnostics Schedules Third Quarter Earni .. Release and Conference Call for November 4, 2010
[ Mon, Oct 18th 2010 ] - Market Wire
Vertex Pharmaceuticals Initiates Clinical Trial t .. ns of VX-770 and VX-809 Targeting the Defective P
[ Mon, Oct 18th 2010 ] - Market Wire
Lannett Company Launches Fluphenazine HCl Tablets USP
[ Mon, Oct 18th 2010 ] - Market Wire
BioSante Pharmaceuticals Reaches Key LibiGel® Safety Study Enrollment Target
[ Mon, Oct 18th 2010 ] - Market Wire
Celgene Corporation to Announce Third Quarter 2010 Results on October 28, 2010
[ Mon, Oct 18th 2010 ] - Market Wire
Presentacin de nuevos datos que apoyan el ensayo .. 26 Congreso del Comit© Europeo para el tratamien
[ Mon, Oct 18th 2010 ] - Market Wire
St. Jude Medical and AGA Medical Announce Definitive Agreement
[ Mon, Oct 18th 2010 ] - Market Wire
BioCryst Pharmaceuticals to Announce Third Quarter 2010 Financial Results on October 28, 2010
Sun, October 17, 2010
[ Sun, Oct 17th 2010 ] - Market Wire
Neue Daten, die einen mglichen Nutzen des JC-Viru .. den auf dem 26. Kongress des European Committee f
Sat, October 16, 2010
[ Sat, Oct 16th 2010 ] - Market Wire
Des donn©es soutenant l'essai clinique sur les a .. ©es lors du 26e Congrs du Comit© europ©en pour
[ Sat, Oct 16th 2010 ] - Market Wire
Celgene voltooit acquisitie van Abraxis

Celgene voltooit acquisitie van Abraxis


Published on 2010-10-17 08:25:07 - Market Wire
  Print publication without navigation


SUMMIT, N.J.--([ BUSINESS WIRE ])--Celgene Corporation (NASDAQ: CELG) meldt de afronding van de acquisitie van Abraxis BioScience, Inc. Voor elk gewoon aandeel van Abraxis ontvangen aandeelhouders van Abraxis: 58 dollar in contanten, 0,2617 gewone aandelen van Celgene en een verhandelbaar Contingent Value Right (CVR), dat de houder recht geeft op een pro-rato aandeel van mogelijke betalingen voor toekomstige regelgevende mijlpalen en commercile royalties. De CVRs zijn op de NASDAQ genoteerd onder het symbool aCELGZa en komen in de handel naar verwachting bij opening van de markt op maandag 18 oktober 2010. Abraxis-aandelen worden bij de NASDAQ uitgeschreven en handel staakt bij sluiting van de markt op vrijdag 15 oktober 2010.

Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal welke als enige juridische geldigheid beoogt.

Contributing Sources